| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Tunicamycin |
|---|
| Description | A specific inhibitor of N-linked glycoslylation that blocks the first step of glycoprotein synthesis and induces protein unfolding; impairs the function of several receptor tyrosine kinases, including EGFR, ErbB2, ErbB3, IGF-IR, and ALK; radiosensitizes glioma and pancreatic adenocarcinoma cells to chemotherapy (500 nM) and disrupts cell viability in various neuroblastoma cell lines (IC50s 20 - 500 nM) |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 11118-26-6 N-linked glycosylation post-translational modifications proteins folding inhibitors inhibition inhibits antibiotics glycoproteins EGFR ErbB2 ErbB3 IGF-IR ALK cancers palmitoylation oligomerization cells endoplastic reticulum amino acids Golgi plasma membranes nucleoside U251 glioma BXPC3 phosphorylation |
|---|
| Gene, Accession, CAS # | CAS: 11089-65-9 |
|---|
| Catalog # | 11445-5 |
|---|
| Price | |
|---|
| Order / More Info | Tunicamycin from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|